As described above, NHERF‐I, NHERF‐II, and PDZK1 are abundantly expressed in breast cancer or cell lines, where NBCn1 expression is upregulated by 20–30% compared to that in matched normal breast tissue (Boedtkjer et al. 2012). Here, SLC4A7 is linked to breast carcinoma.